Children's environmental health: an under-recognised area in paediatric health care

Tania G Gavidia1, Jenny Pronczuk de Garbino, Peter D Sly

  • 1WHO Collaborating Centre for Research on Children's Environmental Health, Curtin University of Technology, Perth, WA, Australia. tgavidia@ichr.uwa.edu.au

BMC Pediatrics
|February 7, 2009
PubMed

Insights

Adverse environments significantly impact child development and adult health. Healthcare providers need enhanced awareness of children's unique environmental vulnerabilities and related diseases.

Area of Science:

  • Environmental Health
  • Pediatric Health
  • Developmental Pediatrics

Background:

  • Growing recognition of adverse environmental impacts on child development from intrauterine life through adolescence.
  • International focus on children's health and environmental rights, driven by global declarations on sustainable development, chemical safety, and climate change.
  • Established research identifying patterns of childhood environmental diseases, assessing toxicant exposures, and pinpointing vulnerable developmental periods.

Discussion:

  • The critical need to bridge the knowledge gap between environmental health research and pediatric healthcare providers.
  • Highlighting the significant, yet often overlooked, burden of environmentally attributed diseases in children.
  • Emphasizing children's heightened susceptibility to environmental threats compared to adults.

Key Insights:

  • Environmental factors profoundly influence child growth, development, and long-term adult health.
  • Children possess unique vulnerabilities to environmental toxicants during critical developmental windows.
  • Quantified cost-benefits exist for addressing environmentally linked diseases in pediatric populations.

Outlook:

  • Urgent need for increased awareness and education among front-line healthcare professionals regarding environmental health risks in children.
  • Integrating environmental health considerations into routine pediatric care and public health strategies.
  • Future research and policy should prioritize protecting children from environmental hazards to ensure lifelong well-being.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Dimensions of Health and Illness01:21

Dimensions of Health and Illness

The factors influencing the health-illness continuum can be internal or external and may or may not be under conscious control. They are related to the following eight human dimensions, and each dimension is interrelated to one other.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Specialized Care Centers and Settings-II01:30

Specialized Care Centers and Settings-II

Rural Health Centers
Rural health centers are specialized care facilities in remote locations with very few medical personnel. The primary care providers who run the centers are mostly Registered Nurse Practitioners. Here, emergency treatment is provided to critically ill or injured patients before they are transferred to the closest hospital. Fortunately, due to advancement in technology, many rural healthcare facilities and professionals have easy access to diagnostic and treatment...